深 inferior 腹壁穿支(DIEP)皮瓣在偏瘦与非偏瘦BMI患者中的安全性:系统综述与Meta分析
该系统综述与Meta分析比较偏瘦与非偏瘦BMI患者行DIEP皮瓣乳房再造的并发症,纳入7项研究共574例偏瘦与901例非偏瘦患者,两组在完全皮瓣丢失、部分皮瓣丢失、脂肪坏死及总体手术并发症、腹部创面愈合并发症、感染、血清肿方面均无统计学显著差异。
要点
- 偏瘦与非偏瘦BMI患者DIEP皮瓣乳房再造的完全皮瓣丢失、部分皮瓣丢失及脂肪坏死均无统计学显著差异。
- 总体手术并发症、腹部创面愈合并发症、感染及血清肿在两组间均无统计学显著差异。
- 作者认为DIEP皮瓣可安全用于偏瘦患者,但需更高质量研究进一步证实。
核心结论
- 偏瘦与非偏瘦BMI患者行DIEP皮瓣乳房再造术后并发症风险均未见增加,DIEP皮瓣可安全用于偏瘦患者,但作者指出需更高质量研究进一步证实。
研究设计与样本
- 系统综述与Meta分析,按照PRISMA指南于2021年2月1日检索Cochrane、EMBASE、OVID Medline、PubMed和Web of Sciences多数据库,采用逆方差统计模型分析,纳入7项研究共574例偏瘦患者和901例非偏瘦BMI患者行自体DIEP皮瓣乳房再造。
主要发现
- 偏瘦组与非偏瘦组完全皮瓣丢失OR=0.53(95%CI:0.11-2.68,p=0.44),无统计学显著差异。
- 偏瘦组与非偏瘦组部分皮瓣丢失OR=0.92(95%CI:0.3-2.82,p=0.88),无统计学显著差异。
- 偏瘦组与非偏瘦组脂肪坏死OR=0.91(95%CI:0.61-1.37,p=0.66),无统计学显著差异。
- 偏瘦组与非偏瘦组所有并发症OR=0.83(95%CI:0.45-1.51,p=0.54)、腹部创面愈合并发症OR=1.01(95%CI:0.59-1.73,p=0.97)、感染OR=0.74(95%CI:0.41-1.37,p=0.34)、血清肿OR=0.89(95%CI:0.35-227,p=0.81),均无统计学显著差异。
临床怎么用
- 作者认为DIEP皮瓣可安全用于偏瘦患者,但指出需更高质量研究进一步证实。
局限性
- 作者指出需更高质量研究进一步证实DIEP皮瓣在偏瘦患者中的安全性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND/PURPOSE: The complications of breast reconstruction using deep inferior epigastric perforator (DIEP) flaps in non-slim patients are well recognized. However, the effects of this surgery performed on slim patients are yet to be consolidated. This study aims to compare the outcomes of performing DIEP flap breast reconstruction in slim and non-slim body mass index (BMI) patients. METHODS: Meta-analysis was performed with a multi-database search (Cochrane, EMBASE, OVID Medline, PubMed, and Web of Sciences) according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines on 1 February 2021. Data from articles meeting inclusion criteria were extracted and analyzed with an inverse variance statistical model. RESULTS: Seven studies were included, comprising 574 slim patients and 901 non-slim BMI patients who underwent autologous DIEP flap breast reconstruction. When comparing between the slim and non-slim groups, no statistically significant difference was found in terms of complete flap loss (OR=0.53, 95% CI: 0.11-2.68, p=0.44), partial flap loss (OR=0.92, 95% CI: 0.3-2.82, p=0.88), and fat necrosis (OR=0.91, 95% CI: 0.61-1.37, p=0.66). Similarly, in terms of general surgical complications, there was no statistically significant difference between groups in terms of all complications (OR=0.83, 95% CI: 0.45-1.51, p=0.54), abdominal wound healing complications (OR=1.01, 95% CI: 0.59-1.73, p=0.97), infections (OR=0.74, 95% CI: 0.41-1.37, p=0.34), and seroma (OR=0.89, 95% CI: 0.35-227, p=0.81). CONCLUSION: There is no increased risk of postoperative complications in either group. DIEP flaps can be safely performed in slim patients, though higher quality research may be required to further confirm this.
引用
- Tan MYL, Onggo J, Serag S, et al. Deep inferior epigastric perforator (DIEP) flap safety profile in slim versus non-slim BMI patients: A systematic review and meta-analysis. J Plast Reconstr Aesthet Surg. 2022. PMID: 35650004. doi:10.1016/j.bjps.2022.04.046
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。